At a glance
- Originator Sankyo
- Class Class Ic antiarrhythmics; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias
Most Recent Events
- 07 Jul 1995 Preclinical development for Arrhythmias in Japan (Unknown route)
- 23 Jun 1995 No-Development-Reported for Arrhythmias in Japan (Unknown route)